Skip to content Skip to navigation

Social:

RSS:

Vatican Radio

The voice of the Pope and the Church in dialogue with the World

language:

stem cells

Dr. Patrick Soon-Shiong is welcomed by Pope Francis at audience for participants of a Vatican conference on regenerative medicine 28-30 April 2016

Dr. Patrick Soon-Shiong is welcomed by Pope Francis at audience for participants of a Vatican conference on regenerative medicine 28-30 April 2016

Regenerative Medicine: Dr. Soon-Shiong on hopes for Cancer vaccine

10/05/2016 16:30

Vatican Radio's Tracey McClure speaks with Dr. Patrick Soon-Shiong, recipient of the 2016 Pontifical Key Visionary Award for "medical innovators who change the course of history and reduce suffering on a global scale." Learn more about his work to develop a vaccine against cancer...

Vatican Regenerative Medicine conference focuses on revolutionary therapies to treat cancer, autoimmune disorders and more

Vatican Regenerative Medicine conference focuses on revolutionary therapies to treat cancer, autoimmune disorders and more

Vatican Regenerative Medicine conference Day 2

29/04/2016 18:14

The body can work as its own “pharmacy” with its own tool kit to heal itself – that’s one of the revolutionary concepts to come out of a Vatican conference on regenerative medicine and its cultural impact on society. 

Vatican regenerative medicine conference opens with focus on kids, rare disease

Vatican regenerative medicine conference opens with focus on kids, rare disease

Vatican cell conference opens with focus on kids, rare disease

29/04/2016 06:49

The President of the Pontifical Council for Culture partnered with the Stem For Life Foundation to organize what has been described as a “historic” three day event 28-30 April to look at the complex cultural and social framework of illnesses and at cutting edge research into cellular therapies.

 

A model of a foetus

A model of a foetus

Concern over new clinical stem cell trial

12/10/2015 11:59

A new clinical trial has been announced that will involve injecting foetal stem cells into babies still in the womb. The trial is already raising serious concerns as the stem cells will come from terminated pregnancies.